6533b824fe1ef96bd128096e

RESEARCH PRODUCT

Prognostic scores for hepatocellular carcinoma: none is the winner

Giuseppe CabibboCalogero CammàGiuseppe Cabibbo

subject

OncologyCancer classificationmedicine.medical_specialtyHepatologybusiness.industryTumour stagingmedicine.diseaseTumour stageHepatocellular carcinomaInternal medicinemedicineIn patientNeoplasm stagingbusinessSurvival rate

description

Cancer classification and indication of treatment are critical steps in the management of patients with hepatocellular carcinoma (HCC). The prediction of outcome is relevant to provide adequate information to patients and relatives, both at the time of treatment selection and after the application of therapy. Tumour staging describes the extent of an individual's tumour burden in the original primary organ and spread throughout the body, and other cofactors such as age or histological grade are only seldom considered. This is common to all malignancies and diseases. However, whereas for most neoplasms prognosis and treatment are largely dictated by tumour stage at the time of diagnosis, the scenario is more complex in patients with HCC.

https://doi.org/10.1111/j.1478-3231.2009.01994.x